Washington, DC
May 22–23, 2023
Seating is limited. For more information about this event, contact Lucinda Lanier.
Monday, May 22
1:05–1:45 pm
- Luca Maini, Harvard Medical School
Mergers that Matter: The Impact of M&A Activity in Prescription Drug Markets
1:45–2:25 pm
- Joshua Gottlieb, University of Chicago Harris School of Public Policy
Market Size and Trade in Medical Services
2:40–3:20 pm
- Abby Alpert, University of Pennsylvania Wharton Health Care Management
Opioid Use and Employment Outcomes: Evidence from the US Military
3:20–4:00 pm
- David Bradford, University of Georgia School of Public & International Affairs
Harm Reduction in the Real World: Evidence from a Large Unplanned Harm Reduction Shock to the US Illicit Opioid Market
6:30–8:00 pm
- Anna Kaltenboeck, ATI Advisory
Keynote address
Anna Kaltenboeck is Head of the Prescription Drug Reimbursement Practice at ATI Advisory. Prior to joining ATI, she was Senior Health Advisor on the Senate Committee on Finance, where she led on drug pricing issues, including Medicare negotiation. In her previous role as Program Director for the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center, she studied how reimbursement policies shape the market for prescription drugs.
Tuesday, May 23
9:00:–9:40 am
- Charu Gupta, UCLA Anderson School of Management
One Product, Many Patents: Imperfect Intellectual Property Rights in the Pharmaceutical Industry
9:40–10:20 am
- Joshua Krieger, Harvard Business School
Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency
10:30–11:10 am
- Jetson Leder-Luis, Boston University Questrom School of Business
Dying or Lying? For-Profit Hospices and End-of-Life Care
11:10–11:50 am
- Michael Daly, Cornell University Brooks School of Public Policy
The Effects of Physicians' Financial Transfers from Drug Firms on Prescribing of Physician-Administered Cancer Drugs
1:45–2:25 pm
- Anna Chorniy, Northwestern University Feinberg School of Medicine
Administrative Burdens and Child Medicaid Enrollments
2:25–3:05 pm
- Ted Frech, University of California Santa Barbara
Pharmaceutical Pricing and R&D as a Global Public Good
3:05–3:45 pm
- Stuart Craig, Tobin Center for Economic Policy, Yale University
Who Bears the Burden of Rising Health Care Spending in the US? Evidence from Hospital Mergers
